Synthamin 17 infusion 500ml bags

Země: Velká Británie

Jazyk: angličtina

Zdroj: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktivní složka:

L-Leucine; L-Isoleucine; L-Valine; L-Lysine; L-Threonine; Tryptophan; L-Alanine; L-Arginine; Glycine; L-Proline; L-Serine; L-Tyrosine; Sodium acetate; Dipotassium hydrogen phosphate; Sodium chloride; Magnesium chloride; L-Phenylalanine; L-Histidine; L-Methionine

Dostupné s:

Baxter Healthcare Ltd

ATC kód:

B05BA01

INN (Mezinárodní Name):

L-Leucine; L-Isoleucine; L-Valine; L-Lysine; L-Threonine; Tryptophan; L-Alanine; L-Arginine; Glycine; L-Proline; L-Serine; L-Tyrosine; Sodium acetate; Dipotassium hydrogen phosphate; Sodium chloride; Magnesium chloride; L-Phenylalanine; L-Histidine; L-Methionine

Dávkování:

7.3gram/1litre ; 6gram/1litre ; 5.8gram/1litre ; 5.8gram/1litre ; 4.2gram/1litre ; 1.8gram/1litre ; 20.7gram/1litre ; 11.5gram/1litre ; 10.3gram/1litre ; 6.8gram/1litre ; 5gram/1litre ; 400mg/1litre ; 6.8gram/1litre ; 5.2gram/1litre ; 1.17gram/1litre ; 1.02gram/1litre ; 5.6gram/1litre ; 4.8gram/1litre ; 4gram/1litre

Léková forma:

Infusion

Podání:

Intravenous

Třída:

No Controlled Drug Status

Druh předpisu:

Never Valid To Prescribe As A VMP

Přehled produktů:

BNF: 09030000; GTIN: 55413760019340 05413760019345

Charakteristika produktu

OBJECT 1
SYNTHAMIN 17, 10% AMINO ACID INTRAVENOUS
INFUSION
Summary of Product Characteristics Updated 08-Jul-2015 | Baxter
Healthcare Ltd
1. Name of the medicinal product
Synthamin 17, 10% Amino Acid Intravenous Infusion
2. Qualitative and quantitative composition
L-Leucine
Ph. Eur
0.730% w/v
L-Isoleucine
Ph. Eur
0.600% w/v
L-Lysine (as hydrochloride
salt)
Ph. Eur
0.580% w/v
L-Valine
Ph. Eur
0.580% w/v
L-Phenylalanine
Ph. Eur
0.560% w/v
L-Histidine
Ph. Eur
0.480% w/v
L-Threonine
Ph. Eur
0.420% w/v
L-Methionine
Ph. Eur
0.400% w/v
L-Tryptophan
Ph. Eur
0.180% w/v
L-Alanine
Ph. Eur
2.070% w/v
L-Arginine
Ph. Eur
1.150% w/v
Amino acetic acid (glycine)
Ph. Eur
1.030% w/v
L-Proline
Ph. Eur
0.680% w/v
L-Serine
Ph. Eur
0.500% w/v
L-Tyrosine
Ph. Eur
0.040% w/v
Sodium acetate
Ph. Eur.
0.680% w/v
Dibasic potassium phosphate
Ph. Eur.
0.522% w/v
Sodium chloride
Ph. Eur.
0.117% w/v
Magnesium chloride
Ph. Eur.
0.102% w/v
3. Pharmaceutical form
The product is a sterile aqueous solution of amino acids and
electrolytes for intravenous infusion to
human beings.
4. Clinical particulars
4.1 Therapeutic indications
Synthamin 17, 10% Amino Acid Intravenous Infusion provides a
biologically available source of nitrogen
(L-amino acids) for amino acids synthesis. When administered with an
adequate source of energy such as
concentrated carbohydrate solutions, minerals and vitamins, the
mixture provides (with the exception of
essential fatty acids) sufficient parenteral nutrition for patients
unable to absorb adequate oral nutrition.
4.2 Posology and method of administration
The solution is for administration by intravenous infusion through a
central venous catheter with the tip
located in the central vena cava. The total daily dose of the solution
depends upon the patient's metabolic
requirement and clinical response. The determination of nitrogen
balance and accurate daily body
weights, corrected for fluid balance, are probably the best means of
assessing individual nitrogen
requirements.
In addition to meeting nitrogen needs, the rate of ad